COMPARISON OF 3 HIGH-AFFINITY SPECT RADIOTRACERS FOR THE DOPAMINE-D-2 RECEPTOR

被引:22
作者
ALTIKRITI, MS
BALDWIN, RM
ZEAPONCE, Y
SYBIRSKA, E
ZOGHBI, SS
LARUELLE, M
MALISON, RT
KUNG, HF
KESSLER, RM
CHARNEY, DS
HOFFER, PB
INNIS, RB
机构
[1] YALE UNIV,VET ADM MED CTR,DEPT DIAGNOST RADIOL,W HAVEN,CT 06516
[2] UNIV PENN,PHILADELPHIA,PA 19104
[3] VANDERBILT UNIV,NASHVILLE,TN 37240
来源
NUCLEAR MEDICINE AND BIOLOGY | 1994年 / 21卷 / 02期
关键词
D O I
10.1016/0969-8051(94)90007-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The regional brain distribution and pharmacological specificity of three high affinity tracers for the dopamine (DA) D-2 receptor: [I-123]IBF, [I-123]epidepride, and [I-123]2'-ISP were assessed by SPECT imaging of non-human primates. The ratios of striatal-to-occipital activities at the time of peak striatal uptake were 2.2, 6.3 and 1.7, respectively. From the peak striatal activities, washout rates were 33, 4 and 16%/h for [I-123]IBF, [I-123]epidepride and [I-123]2'-ISP, respectively. The reversibility of the striatal uptake of all three agents was demonstrated by the rapid displacement induced by the dopamine D, selective antipsychotic agent raclopride, which increased washout rates to 96, 58 and 43%/h. The administration of d-amphetamine, which induces release of dopamine, had no noticeable effect on [I-123]epidepride but increased the washout rate of [I-123]IBF. These results suggest that, among these three agents, [I-123]epidepride is the superior tracer for in vivo displacement studies because of its slow washout and high target-to-background ratios. However, for tracer kinetic modeling, [I-123]IBF may be the superior agent because of its early time of peak uptake and its higher target-to-background ratios than [I-123]2'-ISP.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 36 条
[11]  
INNIS RB, 1991, J NUCL MED, V32, P1654
[12]   REGIONAL BRAIN MEASUREMENT OF BMAX AND KD WITH THE OPIATE ANTAGONIST CYCLOFOXY - EQUILIBRIUM STUDIES IN THE CONSCIOUS RAT [J].
KAWAI, R ;
CARSON, RE ;
DUNN, B ;
NEWMAN, AH ;
RICE, KC ;
BLASBERG, RG .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (04) :529-544
[13]  
KESSLER R M, 1990, Journal of Nuclear Medicine, V31, P779
[14]  
KESSLER RM, 1991, J NUCL MED, V32, P1593
[15]  
KLAWANS HL, 1980, AM J PSYCHIAT, V137, P900
[16]  
KUNG H F, 1991, Journal of Nuclear Medicine, V32, P1008
[17]   COMPARISON OF INVIVO D-2 DOPAMINE RECEPTOR-BINDING OF IBZM AND NMSP IN RAT-BRAIN [J].
KUNG, HF ;
BILLINGS, JJ ;
GUO, YZ ;
MACH, RH .
NUCLEAR MEDICINE AND BIOLOGY, 1988, 15 (02) :203-&
[18]  
KUNG HF, 1989, J NUCL MED, V30, P88
[19]  
KUNG MP, 1990, J NUCL MED, V31, P648
[20]   THE NEXT FRONTIER IN PARKINSONS-DISEASE - PRESYMPTOMATIC DETECTION [J].
LANGSTON, JW ;
KOLLER, WC .
NEUROLOGY, 1991, 41 (05) :5-7